Skip to main content

Table 1 Clinico-pathological features of the breast cancer cohort (n = 157)

From: PSMD9 expression predicts radiotherapy response in breast cancer

Characteristic

Category

Number of cases (%)

Age (years)

Median: 59

 

Range: 31-93

Surgery

Wide local excision

89 (56.7)

Mastectomy

68 (43.3)

Grade

1

29 (18.5)

2

73 (46.5)

3

55 (35.0)

Size (cm)

<2

73 (46.5)

2-5

69 (43.9)

>5

15 (9.6)

Hormone receptors

ER +

111 (70.7)

ER -

46 (29.2)

HER2 +

4 (2.5)

HER2 -

18 (11.5)

HER2 unknown

135 (86.0)

LN status (number positive nodes)

0

86 (54.8)

1-3

40 (25.5)

4+

26 (16.6)

Unknown

5 (3.2)

Adjuvant therapy

Chemotherapy

40 (25.5)

No chemotheray

117 (74.5)

Endocrine

115 (73.2)

No endocrine

29 (18.5)

Endocrine unknown

13 (8.3)

RT

110 (70.1)

No RT

47 (29.9)

Local recurrence

Yes

32 (20.4)

No

125 (79.6)

Systemic recurrence

Yes

49 (31.2)

No

108 (68.8)

Follow-up (months)

Median: 96

 

Range: 9-220